Linaclotide Capsules - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > Linaclotide Capsules - Global Top Players Market Share and Ranking 2025

Linaclotide Capsules - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-12-09
Report Id: 2861296
Industry: Pharma & Healthcare
Report Page: 99
Chart: 90

PDF Download

Publication Date: 2025-12-09
Report Id: 2861296
Industry: Pharma & Healthcare
Report Page: 99
Chart: 90

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Linaclotide Capsules Definition
1.2 Global Linaclotide Capsules Market Size and Forecast
1.2.1 By Consumption Value, Global Linaclotide Capsules Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Linaclotide Capsules Market Size, 2020-2031
1.2.3 Global Linaclotide Capsules Average Selling Price (ASP), 2020-2031
1.3 China Linaclotide Capsules Market Size and Forecast
1.3.1 By Consumption Value, China Linaclotide Capsules Market Size, 2020-2031
1.3.2 By Sales Quantity, China Linaclotide Capsules Market Size, 2020-2031
1.3.3 China Linaclotide Capsules Average Selling Price (ASP), 2020-2031
1.4 Share of China Linaclotide Capsules Market with Respect to the Global Market
1.4.1 By Consumption Value, China Linaclotide Capsules Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Linaclotide Capsules Market Share in Global, 2020-2031
1.4.3 Linaclotide Capsules Market Size: China VS Global, 2020-2031
1.5 Linaclotide Capsules Market Dynamics
1.5.1 Linaclotide Capsules Market Drivers
1.5.2 Linaclotide Capsules Market Restraints
1.5.3 Linaclotide Capsules Industry Trends
1.5.4 Linaclotide Capsules Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Linaclotide Capsules, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Linaclotide Capsules, Global Market Share by Company, 2020-2025
2.3 Linaclotide Capsules Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Linaclotide Capsules Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Linaclotide Capsules Concentration Ratio
2.6 Global Linaclotide Capsules Mergers & Acquisitions, Expansion Plans
2.7 Global Linaclotide Capsules Manufacturers Product Type
2.8 Head Office and Linaclotide Capsules Production Site of Key Manufacturer
2.9 Linaclotide Capsules Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Linaclotide Capsules, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Linaclotide Capsules, China Market Share by Company, 2020-2025
3.3 China Linaclotide Capsules Linaclotide Capsules Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Linaclotide Capsules Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Linaclotide Capsules Capacity by Region
4.3 Global Linaclotide Capsules Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Linaclotide Capsules Production by Region, 2020-2031
4.5 Global Linaclotide Capsules Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Linaclotide Capsules Industry Chain
5.2 Linaclotide Capsules Upstream Analysis
5.2.1 Linaclotide Capsules Core Raw Materials
5.2.2 Main Manufacturers of Linaclotide Capsules Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Linaclotide Capsules Production Mode
5.6 Linaclotide Capsules Procurement Model
5.7 Linaclotide Capsules Industry Sales Model and Sales Channels
5.7.1 Linaclotide Capsules Sales Model
5.7.2 Linaclotide Capsules Typical Distributors

6 Sights by Type
6.1 Linaclotide Capsules Classification by Type
6.1.1 72μg
6.1.2 145μg
6.1.3 290μg
6.2 by Type, Global Linaclotide Capsules Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Linaclotide Capsules Consumption Value, 2020-2031
6.4 by Type, Global Linaclotide Capsules Sales Quantity, 2020-2031
6.5 by Type, Global Linaclotide Capsules Average Selling Price (ASP), 2020-2031

7 Sights by Production Model
7.1 Linaclotide Capsules Classification by Production Model
7.1.1 In-House Manufactured API
7.1.2 CDMO Contract Production API
7.1.3 Others
7.2 by Production Model, Global Linaclotide Capsules Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Production Model, Global Linaclotide Capsules Consumption Value, 2020-2031
7.4 by Production Model, Global Linaclotide Capsules Sales Quantity, 2020-2031
7.5 by Production Model, Global Linaclotide Capsules Average Selling Price (ASP), 2020-2031

8 Sights by Therapeutic Area
8.1 Linaclotide Capsules Classification by Therapeutic Area
8.1.1 Chronic Constipation Treatment
8.1.2 IBS-C Treatment
8.1.3 Others
8.2 by Therapeutic Area, Global Linaclotide Capsules Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Therapeutic Area, Global Linaclotide Capsules Consumption Value, 2020-2031
8.4 by Therapeutic Area, Global Linaclotide Capsules Sales Quantity, 2020-2031
8.5 by Therapeutic Area, Global Linaclotide Capsules Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Linaclotide Capsules Segment by Application
9.1.1 Hospitals
9.1.2 Clinics
9.1.3 Others
9.2 by Application, Global Linaclotide Capsules Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Linaclotide Capsules Consumption Value, 2020-2031
9.4 by Application, Global Linaclotide Capsules Sales Quantity, 2020-2031
9.5 by Application, Global Linaclotide Capsules Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Linaclotide Capsules Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Linaclotide Capsules Consumption Value, 2020-2031
10.3 By Region, Global Linaclotide Capsules Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Linaclotide Capsules Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Linaclotide Capsules Market Size Market Share
10.5 Europe
10.5.1 Europe Linaclotide Capsules Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Linaclotide Capsules Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Linaclotide Capsules Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Linaclotide Capsules Market Size Market Share
10.7 South America
10.7.1 South America Linaclotide Capsules Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Linaclotide Capsules Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Linaclotide Capsules Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Linaclotide Capsules Consumption Value, 2020-2031
11.3 By Country, Global Linaclotide Capsules Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Linaclotide Capsules Market Size, 2020-2031
11.4.2 by Type, United States Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Linaclotide Capsules Market Size, 2020-2031
11.5.2 by Type, Europe Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Linaclotide Capsules Market Size, 2020-2031
11.6.2 by Type, China Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Linaclotide Capsules Market Size, 2020-2031
11.7.2 by Type, Japan Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Linaclotide Capsules Market Size, 2020-2031
11.8.2 by Type, South Korea Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Linaclotide Capsules Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Linaclotide Capsules Market Size, 2020-2031
11.10.2 by Type, India Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Linaclotide Capsules Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Linaclotide Capsules Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 AbbVie
12.1.1 AbbVie Company Information, Head Office, Market Area, and Industry Position
12.1.2 AbbVie Linaclotide Capsules Models, Specifications, and Application
12.1.3 AbbVie Linaclotide Capsules Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 AbbVie Company Profile and Main Business
12.1.5 AbbVie Recent Developments
12.2 Astellas
12.2.1 Astellas Company Information, Head Office, Market Area, and Industry Position
12.2.2 Astellas Linaclotide Capsules Models, Specifications, and Application
12.2.3 Astellas Linaclotide Capsules Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Astellas Company Profile and Main Business
12.2.5 Astellas Recent Developments
12.3 AstraZeneca
12.3.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
12.3.2 AstraZeneca Linaclotide Capsules Models, Specifications, and Application
12.3.3 AstraZeneca Linaclotide Capsules Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 AstraZeneca Company Profile and Main Business
12.3.5 AstraZeneca Recent Developments
12.4 Mylan Pharmaceuticals
12.4.1 Mylan Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.4.2 Mylan Pharmaceuticals Linaclotide Capsules Models, Specifications, and Application
12.4.3 Mylan Pharmaceuticals Linaclotide Capsules Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Mylan Pharmaceuticals Company Profile and Main Business
12.4.5 Mylan Pharmaceuticals Recent Developments
12.5 Aurobindo Pharma
12.5.1 Aurobindo Pharma Company Information, Head Office, Market Area, and Industry Position
12.5.2 Aurobindo Pharma Linaclotide Capsules Models, Specifications, and Application
12.5.3 Aurobindo Pharma Linaclotide Capsules Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Aurobindo Pharma Company Profile and Main Business
12.5.5 Aurobindo Pharma Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Linaclotide Capsules should grow from US$ 3024 million in 2024 to US$ 4394 million by 2031, with a CAGR of 5.5% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Linaclotide Capsules

According to YH Research, the global market for Linaclotide Capsules should grow from US$ 3024 million in 2024 to US$ 4394 million by 2031, with a CAGR of 5.5% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Linaclotide Capsules, indicated for chronic constipation and IBS-C, rely on Linaclotide API, pharmaceutical excipients (including microcrystalline cellulose, lactose, and coating agents), capsule shells, blister and secondary packaging materials, as well as QC and batch-release consumables as their upstream inputs. Downstream customers encompass global prescription drug manufacturers, hospital procurement channels, retail pharmacy networks, commercial insurance reimbursement systems, cross-border and direct-to-consumer distribution channels, and clinical research as well as real-world safety evaluation institutions. In 2024, global production capacity is estimated at approximately 850 million capsules, with sales volume around 790 million capsules; the average ex-factory price per capsule is approximately USD 3.6, and the industry maintains an average gross margin of 60%–70%, offering stable commercial returns and growth potential in patient penetration. Driven by global population aging, increasing awareness of functional gastrointestinal disorders, evolving prescription practices in gastroenterology, and long-term therapy demand, the global market for Linaclotide Capsules continues to expand. However, it faces constraints from reimbursement negotiations, generic entry, regional price variations, and increasing regulatory compliance costs, shifting market competition from single sales-driven dynamics toward comprehensive strategies including brand lifecycle management, indication expansion, and formulation innovation.

Linaclotide Capsules hold a significant position in the global functional gastrointestinal disorder treatment market, supported by consistent clinical efficacy and high patient adherence, earning long-term recognition from prescription drug manufacturers and healthcare channels. The current market landscape shows steady penetration in mature markets while educational and promotional efforts in emerging regions are gradually increasing, forming a stable global prescription demand foundation. The robust production and supply chain—including high-purity API supply, excipients and formulation control, quality testing, and batch release—ensures reliability in both commercial and clinical applications.

Future development trends indicate that the Linaclotide Capsule market will continue to benefit from population aging, increased awareness of functional gastrointestinal disorders, growth in long-term therapy demand, and optimized gastroenterology prescription structures. As global healthcare systems place greater focus on chronic constipation and IBS-C treatment, market education, patient management programs, and long-term prescription support policies will further expand the potential patient base, while formulation optimization and dosage form extensions will provide differentiated competitive advantages for manufacturers.

Market drivers include sustained clinical demand, high patient adherence, brand recognition, mature distribution channels, commercial collaboration models, and the ability of formulation companies to capture higher margins through lifecycle management, indication expansion, and channel optimization. At the same time, stricter regulatory requirements, changes in reimbursement and pricing policies, generic drug entry, regional price differences, and rising quality and compliance costs represent significant constraints on market growth. Manufacturers must balance cost control, regulatory compliance, global market coverage, and long-term brand strategy to maintain competitive strength.

Overall, the global market performance of Linaclotide Capsules is stable, with rational and sustainable growth. With formulation improvements, enhanced market education, expanding patient bases, and brand extension strategies, market potential continues to be realized. Profitability and market share in high-end segments are expected to improve steadily, although manufacturers must remain vigilant regarding generic competition and policy-related risks that could affect growth dynamics.

This report studies and analyses global Linaclotide Capsules status and future trends, helps the client to determine the Linaclotide Capsules market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Linaclotide Capsules, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Linaclotide Capsules market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Linaclotide Capsules sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Linaclotide Capsules sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Linaclotide Capsules key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Linaclotide Capsules key producing regions, capacity, production, and year over year growth
(6) Linaclotide Capsules industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    AbbVie
    Astellas
    AstraZeneca
    Mylan Pharmaceuticals
    Aurobindo Pharma

Market segment by Type, covers
    72μg
    145μg
    290μg

Market segment by Production Model, covers
    In-House Manufactured API
    CDMO Contract Production API
    Others

Market segment by Therapeutic Area, covers
    Chronic Constipation Treatment
    IBS-C Treatment
    Others

Market segment by Application, can be divided into
    Hospitals
    Clinics
    Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Linaclotide Capsules product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Linaclotide Capsules market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Linaclotide Capsules market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Linaclotide Capsules, percent & CAGR, 2020-2031
Chapter 5: Linaclotide Capsules industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.